Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1996 1
1997 1
1998 2
1999 2
2000 2
2001 5
2002 5
2003 7
2004 9
2005 8
2006 5
2007 7
2008 5
2009 8
2010 6
2011 3
2012 7
2013 9
2014 4
2015 6
2016 7
2017 8
2018 3
2019 4
2020 6
2021 1
2023 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2).
Kucharzik T, Dignass A, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengiesser K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators. Kucharzik T, et al. Z Gastroenterol. 2024 May;62(5):769-858. doi: 10.1055/a-2271-0994. Epub 2024 May 8. Z Gastroenterol. 2024. PMID: 38718808 Free article. German. No abstract available.
Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009.
Kucharzik T, Dignass A, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengiesser K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Kucharzik T, et al. Z Gastroenterol. 2023 Aug;61(8):1046-1134. doi: 10.1055/a-2060-0935. Epub 2023 Aug 14. Z Gastroenterol. 2023. PMID: 37579791 Free article. German. No abstract available.
Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline.
Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Kucharzik T, et al. Z Gastroenterol. 2020 Dec;58(12):e241-e326. doi: 10.1055/a-1296-3444. Epub 2020 Dec 1. Z Gastroenterol. 2020. PMID: 33260237 German. No abstract available.
Tacrolimus--finally!
Herrlinger KR, Fellermann K, Stange EF. Herrlinger KR, et al. Among authors: fellermann k. Gut. 2006 Sep;55(9):1224-5. doi: 10.1136/gut.2006.093302. Gut. 2006. PMID: 16905691 Free PMC article.
Therapeutic peptides in inflammatory bowel disease.
Herrlinger KR, Stange EF, Fellermann K. Herrlinger KR, et al. Among authors: fellermann k. Expert Opin Biol Ther. 2014 Apr;14(4):455-66. doi: 10.1517/14712598.2014.880109. Expert Opin Biol Ther. 2014. PMID: 24450849 Review.
Thiopurines in inflammatory bowel disease revisited.
Bär F, Sina C, Fellermann K. Bär F, et al. Among authors: fellermann k. World J Gastroenterol. 2013 Mar 21;19(11):1699-706. doi: 10.3748/wjg.v19.i11.1699. World J Gastroenterol. 2013. PMID: 23555158 Free PMC article. Review.
Crohn's disease: a defensin deficiency syndrome?
Fellermann K, Wehkamp J, Herrlinger KR, Stange EF. Fellermann K, et al. Eur J Gastroenterol Hepatol. 2003 Jun;15(6):627-34. doi: 10.1097/00042737-200306000-00008. Eur J Gastroenterol Hepatol. 2003. PMID: 12840673 Review.
Crohn's disease--defect in innate defence.
Gersemann M, Wehkamp J, Fellermann K, Stange EF. Gersemann M, et al. Among authors: fellermann k. World J Gastroenterol. 2008 Sep 28;14(36):5499-503. doi: 10.3748/wjg.14.5499. World J Gastroenterol. 2008. PMID: 18810765 Free PMC article. Review.
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials.
Dignass A, Stremmel W, Horyński M, Poyda O, Armerding P, Fellermann K, Langhorst J, Kuehbacher T, Uebel P, Stein J, Novacek G, Avalueva E, Oliinyk O, Hasselblatt P, Dorofeyev A, Heinemann H, Mueller R, Greinwald R, Reinisch W; International PROTECT-1/2 Study Groups. Dignass A, et al. Among authors: fellermann k. Clin Gastroenterol Hepatol. 2024 Apr;22(4):810-820.e7. doi: 10.1016/j.cgh.2023.09.031. Epub 2023 Oct 6. Clin Gastroenterol Hepatol. 2024. PMID: 37806372 Free article. Clinical Trial.
123 results